420 related articles for article (PubMed ID: 20974918)
1. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
[TBL] [Abstract][Full Text] [Related]
2. A model for transmission of the H3K27me3 epigenetic mark.
Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
[TBL] [Abstract][Full Text] [Related]
3. Role of the polycomb protein EED in the propagation of repressive histone marks.
Margueron R; Justin N; Ohno K; Sharpe ML; Son J; Drury WJ; Voigt P; Martin SR; Taylor WR; De Marco V; Pirrotta V; Reinberg D; Gamblin SJ
Nature; 2009 Oct; 461(7265):762-7. PubMed ID: 19767730
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.
Montgomery ND; Yee D; Montgomery SA; Magnuson T
J Mol Biol; 2007 Dec; 374(5):1145-57. PubMed ID: 17997413
[TBL] [Abstract][Full Text] [Related]
5. Histone methylation by PRC2 is inhibited by active chromatin marks.
Schmitges FW; Prusty AB; Faty M; Stützer A; Lingaraju GM; Aiwazian J; Sack R; Hess D; Li L; Zhou S; Bunker RD; Wirth U; Bouwmeester T; Bauer A; Ly-Hartig N; Zhao K; Chan H; Gu J; Gut H; Fischle W; Müller J; Thomä NH
Mol Cell; 2011 May; 42(3):330-41. PubMed ID: 21549310
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
7. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.
Kuzmichev A; Nishioka K; Erdjument-Bromage H; Tempst P; Reinberg D
Genes Dev; 2002 Nov; 16(22):2893-905. PubMed ID: 12435631
[TBL] [Abstract][Full Text] [Related]
8. PICOT binding to the polycomb group protein, EED, alters H3K27 methylation at the MYT1 PRC2 target gene.
Pandya P; Pasvolsky R; Babichev Y; Braiman A; Witte S; Altman A; Isakov N
Biochem Biophys Res Commun; 2019 Feb; 509(2):469-475. PubMed ID: 30595380
[TBL] [Abstract][Full Text] [Related]
9. Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression.
Ueda T; Nakata Y; Nagamachi A; Yamasaki N; Kanai A; Sera Y; Sasaki M; Matsui H; Honda Z; Oda H; Wolff L; Inaba T; Honda H
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10370-5. PubMed ID: 27578866
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of EZH2 recognition by EED.
Han Z; Xing X; Hu M; Zhang Y; Liu P; Chai J
Structure; 2007 Oct; 15(10):1306-15. PubMed ID: 17937919
[TBL] [Abstract][Full Text] [Related]
11. Recent Structural Insights into Polycomb Repressive Complex 2 Regulation and Substrate Binding.
Kasinath V; Poepsel S; Nogales E
Biochemistry; 2019 Feb; 58(5):346-354. PubMed ID: 30451485
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation.
Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F
Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722
[TBL] [Abstract][Full Text] [Related]
13. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
[TBL] [Abstract][Full Text] [Related]
14. The H3K36me2 Methyltransferase Nsd1 Demarcates PRC2-Mediated H3K27me2 and H3K27me3 Domains in Embryonic Stem Cells.
Streubel G; Watson A; Jammula SG; Scelfo A; Fitzpatrick DJ; Oliviero G; McCole R; Conway E; Glancy E; Negri GL; Dillon E; Wynne K; Pasini D; Krogan NJ; Bracken AP; Cagney G
Mol Cell; 2018 Apr; 70(2):371-379.e5. PubMed ID: 29606589
[TBL] [Abstract][Full Text] [Related]
15. Inner workings and regulatory inputs that control Polycomb repressive complex 2.
O'Meara MM; Simon JA
Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2.
Justin N; Zhang Y; Tarricone C; Martin SR; Chen S; Underwood E; De Marco V; Haire LF; Walker PA; Reinberg D; Wilson JR; Gamblin SJ
Nat Commun; 2016 Apr; 7():11316. PubMed ID: 27121947
[TBL] [Abstract][Full Text] [Related]
17. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells.
Wei Y; Chen YH; Li LY; Lang J; Yeh SP; Shi B; Yang CC; Yang JY; Lin CY; Lai CC; Hung MC
Nat Cell Biol; 2011 Jan; 13(1):87-94. PubMed ID: 21131960
[TBL] [Abstract][Full Text] [Related]
18. Role of histone H3 lysine 27 methylation in Polycomb-group silencing.
Cao R; Wang L; Wang H; Xia L; Erdjument-Bromage H; Tempst P; Jones RS; Zhang Y
Science; 2002 Nov; 298(5595):1039-43. PubMed ID: 12351676
[TBL] [Abstract][Full Text] [Related]
19. C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.
Shi Y; Ma HL; Zhuang YW; Wang XX; Jiang Y; Xu HE
Acta Pharmacol Sin; 2019 Nov; 40(11):1457-1465. PubMed ID: 31186533
[TBL] [Abstract][Full Text] [Related]
20. EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance.
Chu L; Tan D; Zhu M; Qu Y; Ma X; Song BL; Qi W
J Biol Chem; 2023 Apr; 299(4):103073. PubMed ID: 36858198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
